Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

See Locations Near You

Summary

The purpose of the study is to test and understand acceptability and preliminary effectiveness of a mobile educational app specifically customized to patients with advanced Renal Cell Carcinoma (RCC) receiving therapy with combination immunotherapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with Stage IV Renal Cell Carcinoma
Within 3 weeks from starting combination immune checkpoint blockade with tyrosine kinase inhibitor or multikinase inhibitor
Estimated survival of 6 months or more
Able to read and speak English

Exclusion Criteria:

Unable to read or speak English
Enrolled in another clinical trial

Study is for people with:

Kidney Cancer

Estimated Enrollment:

20

Study ID:

NCT05579847

Recruitment Status:

Active, not recruiting

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Moffitt Cancer Center
Tampa Florida, 33612, United States

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

20

Study ID:

NCT05579847

Recruitment Status:

Active, not recruiting

Sponsor:


H. Lee Moffitt Cancer Center and Research Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider